浏览标题索引

标题 文件
卷 6, 编号 2 (2024) Approaches to the compilation of a list of pharmaceuticals and their metabolites subject to state regulation PDF
(Rus)
Shpachuk A., Vilisova M., Sklyarova N.
卷 6, 编号 2 (2024) The last system by Cavalier-Smith PDF
(Rus)
Zmitrovich I., Perelygin V., Zharikov M.
卷 6, 编号 2 (2024) To the 95th anniversary of the birth of Professor Susanna Alexandrovna Minina (1929–2018) PDF
(Rus)
Kaukhova I., Marchenko A., Pivovarova N.
卷 6, 编号 2 (2024) “A brilliant teacher and popularizer”: Professor Pavel Nikolaevich Kashkin (1902–1991) PDF
(Rus)
Narkevich I., Vorobeva S., Perelygin V., Pleshakov I., Сhernych T.
卷 6, 编号 3 (2024) The development of a formulation, the selection and harmonization of the nutrient medium for determining the activity of aminoglycoside antibiotics PDF
(Rus)
Tsvetkova I., Chernykh T., Zharikov M.
卷 6, 编号 3 (2024) State of oncology care in Russia: pancreatic cancer (C25). Diagnosis, prevalence, quality of patient registration, and annual mortality. Part 1. (clinical-population study) PDF
(Rus)
Merabishvili V., Bagnenko S., Balakhnin P., Busko E., Pavlovsky A., Moiseenko V., Perelygin V.
卷 6, 编号 3 (2024) The state of cancer care in Russia: pancreas cancer (C25). The survival rate of patients, taking into account the stage, localization and histological structure. Part II (clinical-population study) PDF
(Rus)
Merabishvili V., Bagnenko S., Balakhnin P., Busko E., Pavlovsky A., Moiseenko V., Statsenko A., Perelygin V.
卷 6, 编号 3 (2024) Contribution of professor Oleg N. Trofimov to the concept of physical education development in the pharmaceutical education system PDF
(Rus)
Tarakanova M., Trofimova E.
卷 6, 编号 4 (2024) Functional reserves and adaptive capabilities of the body in conditions of oxidative stress PDF
(Rus)
Nesteruk A., Shalimov P., Grebennikov N., Vengerovich N., Ustinova T.
卷 6, 编号 4 (2024) The state of oncological care in Russia: malignant skin neoplasms (C44). Part 1. Prevalence, quality of accounting, age characteristics, localization, and histological structure (clinical-population study) PDF
(Rus)
Merabishvili V., Demidov L., Belyaev A., Gafton G., Samoilenko I., Perelygin V.
卷 6, 编号 4 (2024) The state of cancer care in Russia: malignant tumors of the skin (C44). One- and five-years survival of patients, age characteristics. Part II PDF
(Rus)
Merabishvili V., Demidov L., Belyaev A., Gafton G., Samoilenko I., Perelygin V.
卷 6, 编号 4 (2024) Environmental and economic aspects of improving the energy efficiency of the vaccine production life cycle PDF
(Rus)
Yachnikova E., Sklyarova N.
卷 6, 编号 4 (2024) Significant contribution of scientist David Zilber to the development of domestic hygiene and pharmaceutical education PDF
(Rus)
Zilber Y., Perelygin V., Zharikov M., Smirnov A.
卷 2, 编号 3 (2020) Conference "Young pharmacy – the potential of the future» PDF
(Rus)
Narkevich I.
卷 2, 编号 3 (2020) Bioindication of the ecological state (health) of coastal waters based on the use of automatic bioelectronic systems PDF
(Eng)
Kholodkevich S., Kuznetsova T., Kirin M., Smirnov I., Rudakova O., Lyubimtsev V., Manvelova A., Susloparova O., Perelygin V., Sakharova O.
卷 2, 编号 2 (2020) Gravicentric approach to Type 2 Diabetes therapy. The success prediction. A proof-of-concept PDF
(Eng)
levit S., Torban N., Boaz M., Weichman M., Azuri J., Manisterski Y., Merzon E., Ryder D., Ginossar G., Gavra T., Levit V., Domuschiev I., Musin I., Ryder C.
卷 3, 编号 1 (2021) Inonotus rickii (瑞克纤孔菌) 提取物对肌肉收缩强度影响的评估 PDF
(简体中)
PDF
(Rus)
Ranadive K.​., Jagtap N.V., Jagtap P.N., Zmitrovich I.V., Perelygin V.V.
卷 6, 编号 4 (2024) The eukaryotic system in the third update of the interface “Eukaryotic supergroups: Taxonomy/Biotechnology interface”: Formal procedures for rank changes PDF
(Eng)
Zmitrovich I., Perelygin V., Zharikov M.
卷 2, 编号 2 (2020) THE POSSIBILITY OF USING PICTOPOLYGRAPHY IN THE OBJECTIVE DIAGNOSIS OF AFFECTIVE DISORDERS PDF
(Eng)
Shamrey V., Baurova N., Kurasov E., Svechnikov D., Medvedeva J.
卷 2, 编号 3 (2020) Alexander Stepanovich Ardemasov: Party director of the Leningrad Pharmaceutical Institute in 1940-1942 PDF
(Rus)
Narkevich I., Stepanov S., Volgusheva A., Zvyagin Y., Vorobeva S., Perelygin V., Dobrova D.
卷 1, 编号 1 (2019) Alopecia: from clinic to preclinic and back PDF
(Rus)
Ivkin D., Nogaeva U., Flisyuk E., Pisetskaya M., Shtyrlin Y.
卷 1, 编号 1 (2019) A unified and simplified flow diagram of the production of active pharmaceutical ingredients and the finished dosage form PDF
(Rus)
Gabidova A., Galynkin V.
卷 2, 编号 3 (2020) Analysis of the level and dynamics of prices in the pharmaceutical market of Saint Petersburg PDF
(Rus)
Orlov A., Kocherba M.
卷 6, 编号 1 (2024) Analysis of the effectiveness of a new antimicrobial agent for disinfection in veterinary practice PDF
(Rus)
Bukovskaya J., Chernykh T., Zharikov M.
卷 5, 编号 2 (2023) Antimicrobial activity of probiotic strain Enterococcus faecium 1-35 PDF
(Rus)
Brazhnik E., Bikonia S., Laptev G.
卷 5, 编号 2 (2023) Aspects of law enforcement practice of pharmacy organizations of maternity hospitals PDF
(Rus)
Pokhvalenko E., Zolotaryva N., Perelygin V.
卷 5, 编号 1 (2023) The Majestic Landscape of the Eukaryotic Megasystematics PDF
(Rus)
Strugar Y., Tomusjak M.
卷 4, 编号 4 (2022) Taste sensations: the role of sensory analysis in controlling the quality of food products PDF
(Rus)
Lopatin S., Sharonov A., Tyts V., Zharikov M.
卷 2, 编号 2 (2020) COMPARISON OF REQUIREMENTS OF ANNEX 1 TO THE RULES OF GOOD MANUFACTURING PRACTICE OF THE EURASIAN ECONOMIC UNION AND REQUIREMENTS OF THE DRAFT ANNEX 1 GMP PIC/S PDF
(Rus)
Basevich A., Kaukhova I., Kodash A., Bitkina T., Smirnova E., Stepchenkov V.
卷 2, 编号 3 (2020) SUPPORTING DEVICES IN THE TREATMENT OF CHRONIC HEART FAILURE IN ELDERLY AND OLD PATIENTS PDF
(Rus)
Hubulava G., Kozlov K., Bogomolov A., Volkov A., Fedorets V., Senkina E.
卷 1, 编号 1 (2019) Continuous glucose monitoring - proved hypoglycemia in sodium-glucose co-transporter-2 inhibitors - treated type 2 diabetes patients: a link to ketosis development PDF
(Eng)
Levit S., Giveon S., Musin I., Barnea R., Korek-Abadi I., Levit V., Ryder D., Ryder C.
卷 2, 编号 2 (2020) Grigory Yakovlevich Kogan: Director of the Leningrad Pharmaceutical Institute in 1938-1941 PDF
(Rus)
Narkevich I., Stepanov S., Zvyagin Y., Vorobeva S., Perelygin V., Dobrova D.
卷 2, 编号 3 (2020) Malignant neoplasms of the heart, prevalence, weather mortality, median survival and survival of patients, taking into account the stage of diseases, localization and histological structure of tumors PDF
(Rus)
Merabishvili V.
卷 2, 编号 3 (2020) Study of international experience in research of professional activity of pharmaceutical personnel in the context of restrictions, related to the development of the system of professional qualifications in the Russian Federation PDF
(Rus)
Ivanova K., Ilinova J.
卷 5, 编号 3 (2023) Studying the therapeutic effectiveness of a new complex drug in poultry farming PDF
(Rus)
Khlebalina A., Engashev S., Komarov A., Lunegov A.
卷 1, 编号 1 (2019) Discharge Inventory: A New Duty PDF
(Rus)
Subbotinskaya V.
卷 1, 编号 1 (2019) Rabbit models of ischemic stroke in biomedical research PDF
(Rus)
Sysoev Y., Prikhodko V., Ivkin D., Okovity S.
卷 2, 编号 3 (2020) Cariprazine is a modern antipsychotic with a favorable neuroendocrine profile PDF
(Rus)
Dorovskikh I., Pavlova T., Scheidegger J.
卷 5, 编号 2 (2023) Clinical studies of the repellent efficacy of Bars® veterinary drugs in the farms of the Ararat marz of Armenia PDF
(Rus)
Slobodyanik R., Zykova S., Lunegov A., Engasheva E., Dubkov Y.
卷 5, 编号 3 (2023) Correction of piglets’ immune status during critical growing periods PDF
(Rus)
Lunegova I., Lunegov A., Kuznetsov A., Tyts V.
卷 4, 编号 4 (2022) Criticism and bibliography: Zmitrovich I. V., Perelygin V. V., Zharikov M. V. Nomenclature and rank correlation of higher taxa of eukaryotes. Мoscow: INFRA-M, 2022. 183 p. ISBN 978-5-16-018531-6. (Book series “Folia Cryptogamica Petropolitana”. № 8) PDF
(Rus)
Arkhipov M.
卷 2, 编号 3 (2020) Laser synthesis of nanomaterials to create a new family of electrochemical microbiosensors PDF
(Rus)
Kochemirovskaya S., Novomlinsky M., Fogel A., Kochemirovsky V.
卷 5, 编号 4 (2023) Microbiological studies of juniper extract to determine sensitivity to strains of microorganisms PDF
(Rus)
Ivanova K., Lunegov A., Chernykh T., Zenkov K.
卷 5, 编号 2 (2023) Microflora of hatching eggs and ways of its formation PDF
(Rus)
Gorfunkel E., Ilina L.
卷 4, 编号 2 (2022) Monitoring of the safety of plant-based feed by the content of ecotoxicants PDF
(Rus)
Kalyuzhnaya T., Orlova D.
卷 4, 编号 2 (2022) Cardiac arrhythmias and conduction disorders in acute poisoning with cardiotoxic substances PDF
(Rus)
Kruchinin E., Myasnikov V., Tyunin M., Yeltsov A., Yudina N., Perelygin I.
卷 5, 编号 1 (2023) New horizons: the company “NIREX” in pursuit of success and development PDF
(Rus)
Kravchenko A.
卷 2, 编号 3 (2020) About creation of a hybrid multi-level atmospheric air monitoring system in the Republic of Tatarstan PDF
(Rus)
Trofimov O., Rubezhov A., Kraft M., Udaltsov A.
卷 4, 编号 2 (2022) Ensuring food safety in use antimicrobial veterinary drugs in agriculture PDF
(Rus)
Orlova D., Kalyuzhnaya T.
卷 2, 编号 3 (2020) Review and revision of the tribe Baphieae Yakovl. (Fabaceae) PDF
(Rus)
Gonharov M., Yakovlev G.
卷 1, 编号 1 (2019) He created a modern pharmacologist PDF
(Rus)
Narkevich I., Zvyagin Y., Vorobieva S., Perelygin V., Dobrova D.
卷 2, 编号 2 (2020) Determination of the marker compounds for standardization medicinal herbal species «Pectorales tea №1» and «Proctofitol» PDF
(Rus)
Terninko I., Vishnyakov E., Romanova M., Generalova Y.
卷 2, 编号 3 (2020) Organization of practical training on the circulation of labeled drugs at the Saint Petersburg State Chemical and Pharmaceutical University PDF
(Rus)
Siukaeva D.
卷 1, 编号 1 (2019) Features of regulation and control of emissions at the facility of category III PDF
(Rus)
Lamikhova M.
卷 2, 编号 2 (2020) From the editor PDF
(Rus)
Perelygin V.
卷 2, 编号 3 (2020) FROM THE EDITOR PDF
(Rus)
Flisyuk E.
卷 6, 编号 3 (2024) Evaluation of toxicity of feed additive for highly productive animals PDF
(Rus)
Lunegov A., Lunegova I., Svyatkovsky A.
卷 4, 编号 4 (2022) Padevyj toxidrome bee, causes and prevention PDF
(Rus)
Rozhkov K., Lunegova I.
卷 2, 编号 2 (2020) Pathogenetic mechanisms of antinociceptive activity of antidepressants PDF
(Rus)
Scheidegger J., Dorovskiкh I., Pavlova T.
卷 1, 编号 1 (2019) Approaches to a comprehensive solution to the problem of medical waste management PDF
(Rus)
Perelygin V., Sklyarova N., Paramonov S., Pyatizbyantsev T.
卷 4, 编号 4 (2022) Approaches to the Development of Beekeeping on Post-Agricultural Lands in the North-West Federal District of the Russian Federation PDF
(Rus)
Paramonov S., Tomusiak M., Alexandrov M.
卷 2, 编号 3 (2020) Teaching the Humanities and Social Sciences at the Petrograd (Leningrad) Chemical-Pharmaceutical Institute in the 1920s PDF
(Rus)
Narkevich I., Stepanov S., Zvyagin Y., Vorobeva S., Perelygin V., Dobrova D.
卷 5, 编号 4 (2023) The antiarrhythmic activity of amino acid-containing derivatives of 1,4-naphthoquinone PDF
(Rus)
Napalkova S., Buyuklinskaya O.
卷 1, 编号 1 (2019) Creating new drugs design patterns.Step one. Pharmaceutical development PDF
(Rus)
Basevich A., Dzjuba A., Kaukhova I., Andreeva P.
卷 4, 编号 4 (2022) Review of the monograph Zmitrovich I. V., Perelygin V. V., Zharikov M. V. Nomenclature and rank correlation of higher taxa of eukaryotes. Мoscow: INFRA-M, 2022. 183 p. ISBN 978-5-16-018531-6. (Book series “Folia Cryptogamica Petropolitana”. № 8) PDF
(Rus)
Luzhanin V.
卷 2, 编号 2 (2020) Sergey Kholodkevich: "I quite often came up with original ideas, which then turned out to be in demand» PDF
(Rus)
Zvyagin Y.
卷 6, 编号 3 (2024) The Eukaryotic System in the third update of the “Eukaryotic Supergroups: Taxonomy/Biotechnology Interface” (2024) PDF
(Rus)
Zmitrovich I., Perelygin V., Zharikov M.
卷 2, 编号 2 (2020) Retraction Notice Gabidova A., Galynkin V. A unified and simplified flow diagram of the production of active pharmaceutical ingredients and the finished dosage form // Pharmacy Formulas. - 2019. - Т. 1. - №1. - C. 32-37. doi: 10.17816/phf18552 PDF
(Rus)
Gabidova A., Galynkin V.
卷 5, 编号 3 (2023) Standard sample as an obligatory element in the diagnosis of poisoning by toxic substances PDF
(Rus)
Luksha V., Eltsov A., Yudina N.
卷 2, 编号 2 (2020) Structural analysis of drugs assortment for etiopathogenetic therapy of children with acute viral infections PDF
(Rus)
Narkevich I., Nemyatykh O., Timchenko V., Siukaeva D., Terninko T., Alekseeva V.
卷 1, 编号 1 (2019) Tendencies and perspectives of central alpha2-adrenomimetic application in medicobiological research PDF
(Eng)
Vengerovich N., Ivanov I., Proshina Y.
卷 2, 编号 3 (2020) Course of intrahospital coronavirus infection (COVID-19) against the background of preventive and curative administration of peptide immunotropic drugs as part of complex therapy PDF
(Rus)
Petlenko S., Smirnov V., Rudenko V.
卷 1, 编号 1 (2019) Pharmacists in the system of pediatric palliative care: international practice and prospects in Russia PDF
(Rus)
Narkevich I., Nemyatykh O., Medvedeva D.
卷 4, 编号 3 (2022) Formation of water behavior as an element of lifestyle PDF
(Rus)
Lopatin S., Tyts V.
卷 2, 编号 2 (2020) Chaga and its bioactive complexes: history and perspectives PDF
(Rus)
Zmitrovich I., Denisova N., Balandaykin M., Belova N., Bondartseva M., Perevedentseva L., Perelygin V., Yakovlev G.
卷 2, 编号 2 (2020) Experimental study of the liposomal form of fenoterol after improving the method of obtaining it PDF
(Rus)
Ustinova T., Vengerovich N., Judin M.
卷 2, 编号 2 (2020) Electronic workflow for healthcare PDF
(Rus)
Kiryushkin S.
卷 3, 编号 1 (2021) 俄罗斯和俄罗斯联邦西北区肿瘤科客观评估系统的发展阶段 (恶性肿瘤患者发病率、死亡率、登记可靠性、年死亡率、中位生存期、观察存活率和相对存活率),第二部分。 PDF
(简体中)
PDF
(Rus)
Merabishvili V.M., Belyaev A.M.
卷 3, 编号 1 (2021) 俄罗斯和俄罗斯联邦西北区肿瘤科活动客观评估系统的发展阶段 (恶性肿瘤患者发病率、死亡率、登记可靠性、年死亡率、中位存活期、观察存活率和相对存活率),第一部分。 PDF
(简体中)
PDF
(Rus)
Merabishvili V.M., Belyaev A.M.
151 - 229 的 229 信息 << < 1 2 

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».